OPTIMIZE CEFEPIME DOSING IN CRITICALLY ILL PATIENTS RECEIVING CONTINUOUS VENOVENOUS HEMOFILTRATION

被引：0
|
作者：
Lin, Hsin [1 ]
Boidin, Clement [2 ]
Evans, Danielle
Lopez, Natasha [3 ]
Healy, Daniel [4 ]
Serpico, Elena [3 ]
Goutelle, Sylvain [5 ]
Roberts, Jason [6 ]
机构：
[1] Taipei Med Univ Hosp, Taipei, MA, Taiwan
[2] Univ Queensland, Burns Trauma & Crit Care Res Ctr, Brisbane, Qld, Australia
[3] Massachusetts Gen Hosp, Boston, MA 02114 USA
[4] Univ Cincinnati, Cincinnati, OH USA
[5] Hosp Pierre Garraud, Lyon, France
[6] Univ Queensland, Brisbane, Qld, Australia
来源：
CRITICAL CARE MEDICINE | 2019年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
610
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Effect of continuous venovenous hemofiltration with dialysis on lactate clearance in critically ill patients
    Levraut, J
    Ciebiera, JP
    Jambou, P
    Ichai, C
    Labib, Y
    Grimaud, D
    CRITICAL CARE MEDICINE, 1997, 25 (01) : 58 - 62
  • [22] Amino Acid Loss during Continuous Venovenous Hemofiltration in Critically Ill Patients
    Stapel, Sandra N.
    de Boer, Ruben J.
    Thoral, Patrick J.
    Vervloet, Marc G.
    Girbes, Armand R. J.
    Oudemans-van Straaten, Heleen M.
    BLOOD PURIFICATION, 2019, 48 (04) : 321 - 329
  • [23] Gentamicin pharmacokinetics during continuous venovenous hemofiltration in critically ill septic patients
    Petejova, Nadezda
    Zahalkova, Jana
    Duricova, Jana
    Kacirova, Ivana
    Brozmanova, Hana
    Urbanek, Karel
    Grundmann, Milan
    Martinek, Arnost
    JOURNAL OF CHEMOTHERAPY, 2012, 24 (02) : 107 - 112
  • [24] Continuous venovenous hemofiltration:: Effects on monocyte and lymphocyte immunophenotype in critically ill patients
    Rokyta, R
    Holub, M
    Matejovic, M
    Hanzlíková, J
    Helcl, M
    Novák, I
    Srámek, V
    Krouzecky, A
    Príhodová, J
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2002, 25 (11): : 1066 - 1073
  • [25] Discrepancies between observed and predicted continuous venovenous hemofiltration removal of antimicrobial agents in critically ill patients and the effects on dosing
    Bouman, Catherine S. C.
    Van Kan, Hendrikus J. M.
    Koopmans, Richard P.
    Korevaar, JohannaC.
    Schultz, Marcus J.
    Vroom, Margreeth B.
    INTENSIVE CARE MEDICINE, 2006, 32 (12) : 2013 - 2019
  • [26] Discrepancies between observed and predicted continuous venovenous hemofiltration removal of antimicrobial agents in critically ill patients and the effects on dosing
    Catherine S. C. Bouman
    Hendrikus J. M. van Kan
    Richard P. Koopmans
    Johanna C. Korevaar
    Marcus J. Schultz
    Margreeth B. Vroom
    Intensive Care Medicine, 2006, 32 : 2013 - 2019
  • [27] Effect of Extracorporeal Membrane Oxygenation on the New Vancomycin Dosing Regimen in Critically III Patients Receiving Continuous Venovenous Hemofiltration
    Yang, Chi-Ju
    Wu, Chia-Wei
    Wu, Chien-Chih
    THERAPEUTIC DRUG MONITORING, 2018, 40 (03) : 310 - 314
  • [28] Extracorporeal Clearance of Levetiracetam During Continuous Venovenous Hemofiltration in a Critically Ill Patient and New Dosing Recommendation
    le Noble, Jos L. M. L.
    Foudraine, Norbert A.
    Kornips, Francois H. M.
    van Dam, Davy G. H. A.
    Neef, Cees
    Janssen, Paddy K. C.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 57 (04): : 536 - 537
  • [29] Daptomycin pharmacokinetics in critically ill patients receiving continuous venovenous hemodialysis
    Vilay, A. Mary
    Grio, Maricor
    DePestel, Daryl D.
    Sowinski, Kevin M.
    Gao, Lihong
    Heung, Michael
    Salama, Noha N.
    Mueller, Bruce A.
    CRITICAL CARE MEDICINE, 2011, 39 (01) : 19 - 25
  • [30] Measurement and calculation of the extracorporeal elimination of vancomycin during continuous venovenous hemodiafiltration and continuous venovenous hemofiltration in critically ill patients
    Muhl, E
    Bundesen, J
    Iven, H
    Bruch, HP
    JOURNAL OF INTENSIVE CARE MEDICINE, 2001, 16 (05) : 222 - 230
12345